A detailed history of Twinbeech Capital LP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Twinbeech Capital LP holds 240,708 shares of EW stock, worth $17.8 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
240,708
Holding current value
$17.8 Million
% of portfolio
0.32%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$59.7 - $93.78 $14.4 Million - $22.6 Million
240,708 New
240,708 $15.9 Million
Q4 2023

Feb 14, 2024

SELL
$61.71 - $77.76 $46.2 Million - $58.3 Million
-749,263 Reduced 89.97%
83,528 $6.37 Million
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $54 Million - $72.7 Million
778,775 Added 1441.75%
832,791 $57.7 Million
Q2 2023

Aug 14, 2023

BUY
$81.41 - $94.33 $607,481 - $703,890
7,462 Added 16.03%
54,016 $5.1 Million
Q1 2023

May 15, 2023

SELL
$74.26 - $84.51 $6.39 Million - $7.27 Million
-86,033 Reduced 64.89%
46,554 $3.85 Million
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $27 Million - $34.6 Million
-395,130 Reduced 74.88%
132,587 $9.89 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $40.9 Million - $53.2 Million
496,111 Added 1569.67%
527,717 $43.6 Million
Q2 2022

Aug 15, 2022

BUY
$86.5 - $128.27 $2.73 Million - $4.05 Million
31,606 New
31,606 $3.01 Million
Q3 2021

Nov 15, 2021

SELL
$102.91 - $122.75 $2.74 Million - $3.27 Million
-26,633 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$83.84 - $104.76 $2.23 Million - $2.79 Million
26,633 New
26,633 $2.76 Million
Q3 2020

Nov 16, 2020

SELL
$67.19 - $87.44 $271,985 - $353,957
-4,048 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $81,764 - $109,345
1,421 Added 54.09%
4,048 $280,000
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $649,412 - $1 Million
-12,391 Reduced 82.51%
2,627 $496,000
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $1.08 Million - $1.23 Million
15,018 New
15,018 $3.5 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Twinbeech Capital LP Portfolio

Follow Twinbeech Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.